Cargando…

Re-discovering NK cell allo-reactivity in the therapy of solid tumors

Detalles Bibliográficos
Autores principales:	Castagna, Luca, Mavilio, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028947/ https://www.ncbi.nlm.nih.gov/pubmed/27660708 http://dx.doi.org/10.1186/s40425-016-0159-4

Ejemplares similares

Allo-parapatric speciation goes offshore
por: Price, Trevor
Publicado: (2019)

In vitro generation of allo-reactive human NK cells from umblillical cord blood CD34+ progenitor cells
por: Ahn, Yong-Oon, et al.
Publicado: (2015)

T and NK cells: two sides of tumor immunoevasion
por: Fruci, Doriana, et al.
Publicado: (2013)

Inhibiting the inhibitors: Checkpoints blockade in solid tumors
por: Mavilio, Domenico, et al.
Publicado: (2013)

NK Cell Subset Redistribution during the Course of Viral Infections
por: Lugli, Enrico, et al.
Publicado: (2014)

Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma
por: Lin, Adam Yuh, et al.
Publicado: (2023)

Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
por: Clar, Kim L., et al.
Publicado: (2019)

A role for pre-mNK cells in tumor progression
por: Rosinsky, Carolyn, et al.
Publicado: (2016)

Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT
por: Zaghi, Elisa, et al.
Publicado: (2021)

Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?
por: Wang, Luxiang, et al.
Publicado: (2023)

Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans
Publicado: (1992)

Allo-reactive tissue-resident T cells causing damage: An inside job
por: van Lier, René A.W., et al.
Publicado: (2022)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation
por: Stranavova, Lucia, et al.
Publicado: (2019)

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

NK Cells and Trophoblasts: Partners in Pregnancy
por: Parham, Peter
Publicado: (2004)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)

Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019)

Attack of the clones: An NK cell origins story
por: Caporale, Joseph R., et al.
Publicado: (2023)

Supercharged chimeric antigen receptor T cells in solid tumors
por: Pant, Ayush, et al.
Publicado: (2022)

Treatment of solid tumors with immunotoxins
por: Messmer, Davorka, et al.
Publicado: (2005)

NK cells on the ViP stage of COVID-19
por: Masselli, Elena, et al.
Publicado: (2021)

NK cells and solid tumors: therapeutic potential and persisting obstacles
por: Tong, Le, et al.
Publicado: (2022)

Allô France : méthode de français.
por: Leeman, Danielle
Publicado: (1985)

Allô France : méthode de français.
por: Leeman, Danielle
Publicado: (1987)

Allô France : méthode de français.
por: Leeman, Danielle
Publicado: (1987)

Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko Okumura
por: Cooper, Edwin L.
Publicado: (2004)

Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
por: Chan, Jason Yongsheng, et al.
Publicado: (2021)

Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis
por: Pesce, Silvia, et al.
Publicado: (2019)

Beyond Discovering the Viral Agents of Acute Gastroenteritis
por: Glass, Roger
Publicado: (2013)

Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021
por: Sehdev, Sandeep, et al.
Publicado: (2022)

Hepatitis B vaccine and NK cells: a new player in memory
por: Hofmann, Maike, et al.
Publicado: (2021)

Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms
por: D’Orsogna, Lloyd, et al.
Publicado: (2017)

Integrating [(18)F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors
por: Prendergast, Conor M., et al.
Publicado: (2023)

EUS-guided solid pancreatic tumor ablation
por: Dabizzi, Emanuele, et al.
Publicado: (2017)

The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
por: Velichinskii, Rodion A., et al.
Publicado: (2021)

Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
por: Lian, Guangyu, et al.
Publicado: (2021)

Murine models to study human NK cells in human solid tumors
por: Parodi, Monica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ob84pde5pue602a7u0u3d33993